Emmanuel Antonarakis, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Tokai
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Novartis
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Medivation
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Johnson & Johnson
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    GlaxoSmithKline
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Genentech
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Lilly
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Celgene
  • Attribution: 
    Self
    Type of financial relationship: 
    Other
    Ineligible company: 
    Bristol Myers-Squibb
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Bayer

Pages

Return to PARP Inhibitors: Assessing the Clinical Trial Landscape Webcast (2021)